Analysis of the effectiveness rate of rapid serological tests for COVID-19 registered in ANVISA, a systematic review in the literature
DOI:
https://doi.org/10.33448/rsd-v10i11.19615Keywords:
SARS-COV-2; ELISA; COVID-19; Evaluation.Abstract
Introduction: The immunological tests for COVID-19 have the great advantage of their diagnostic speed, but their efficiency rate varies depending on the manufacturer, generating the need to identify the best tests to be used in order to avoid false diagnoses. Objective: To point out the tests available in Brazil, which within the clinical trials sought, have a better rate of effectiveness. Methods: Articles referring to clinical trials that test the effectiveness of rapid tests for the detection of anti-SARS-COV-2 immunoglobulins were searched in the literature. For this purpose, a systematic search was carried out in the SCIELO, LILACS, PUBMED and MEDLINE databases using the descriptors SARS-COV-2, ELISA, COVID-19 and Assessment in association using the Boolean operator AND, followed by the application of criteria for inclusion and exclusion to select the papers to be included in the review. Results: 16 articles that tested 18 of the rapid tests available in the country were included. Conclusion: serological tests are a valuable tool to fight the SARS-COV-2 pandemic, but should not be used as a single tool in the diagnosis of viral infection given the period of immunological window. The ideal use of the tests will occur in cases where the patient already has more than 14 days of symptoms. The One Step COVID-2019 test from Guangzhou Wondfo Biotech revealed the best performance among those analyzed.
References
Banerjee, M., Gupta, S., Sharma, P., Shekhawat, J., & Gauba, K. (2020). Obesity and COVID-19: a fatal alliance. Indian Journal of Clinical Biochemistry, 1-8.
Beavis, K. G., Matushek, S. M., Abeleda, A. P. F., Bethel, C., Hunt, C., Gillen, S., & Tesic, V. (2020). Evaluation of the EUROIMMUN Anti-SARS-CoV-2 ELISA Assay for detection of IgA and IgG antibodies. Journal of Clinical Virology, 129, 104468.
Chansaenroj, J., Yorsaeng, R., Posuwan, N., Puenpa, J., Sudhinaraset, N., Chirathaworn, C., & Poovorawan, Y. (2021). Detection of SARS-CoV-2-specific antibodies via rapid diagnostic immunoassays in COVID-19 patients. Virology Journal, 18(1), 1-7.
Clarke, M., & Horton, R. (2001). Reunindo tudo: Lancet-Cochrane colaboram em revisões sistemáticas. The Lancet, 357 (9270), 1728.
Cordeiro, A. M., Oliveira, G. M. D., Rentería, J. M., & Guimarães, C. A. (2007). Revisão sistemática: uma revisão narrativa. Revista do Colégio Brasileiro de Cirurgiões, 34, 428-431.
Costa, S. F., Buss, L., Espinoza, E. P. S., Vieira Jr, J. M., da Silva, L. C. D. O., de Souza, R. M., & Sabino, E. (2020). Performance of a qualitative rapid chromatographic immunoassay to diagnose COVID-19 in patients in a middle-income country. Journal of Clinical Virology, 131, 104592.
Cota, G., Freire, M. L., de Souza, C. S., Pedras, M. J., Saliba, J. W., Faria, V., & Avelar, D. M. (2020). Diagnostic performance of commercially available COVID-19 serology tests in Brazil. International Journal of Infectious Diseases, 101, 382-390.
Cramer, A., Goodman, N., Cross, T., Gant, V., & Dziadzio, M. (2021). Analytical evaluation and critical appraisal of early commercial SARS-CoV-2 immunoassays for routine use in a diagnostic laboratory. British Journal of Biomedical Science, 78(3), 141-146.
Da Silveira, M. C., & de Azeredo Costa, E. (2020). Busca ativa ou testagem em massa? Cadernos Ibero-Americanos De Direito Sanitário, 9(4), 188-191.
de Souza Carvalho, F. R., Gobbi, L. C., Carrijo-Carvalho, L. C., Caetano, A. J. F., Casotti, G. C., Tiussi, L. M., & Cavalari, A. L. C. (2020). FISIOPATOLOGIA DA COVID-19: REPERCUSSÕES SISTÊMICAS. Unesc em Revista, 4(2), 170-184.
Gutiérrez-Cobos, A., de Frutos, S. G., García, D. D., Lara, E. N., Carrión, A. Y., García-Rodrigo, L. F., & Domingo, L. C. (2021). Evaluation of diagnostic accuracy of 10 serological assays for detection of SARS-CoV-2 antibodies. European Journal of Clinical Microbiology & Infectious Diseases, 40(5), 955-961.
Kohmer, N., Westhaus, S., Rühl, C., Ciesek, S., & Rabenau, H. F. (2020). Brief clinical evaluation of six high-throughput SARS-CoV-2 IgG antibody assays. Journal of Clinical Virology, 129, 104480.
Ministério da Saúde (BR). (2020). Coronavírus Covid-19-Acurácia dos testes diagnósticos registrados na ANVISA para a COVID-19.
Montesinos, I., Gruson, D., Kabamba, B., Dahma, H., Van den Wijngaert, S., Reza, S., & Rodriguez-Villalobos, H. (2020). Evaluation of two automated and three rapid lateral flow immunoassays for the detection of anti-SARS-CoV-2 antibodies. Journal of Clinical Virology, 128, 104413.
Nilsson, A. C., Holm, D. K., Justesen, U. S., Gorm-Jensen, T., Andersen, N. S., Øvrehus, A., & Lillevang, S. T. (2021). Comparison of six commercially available SARS-CoV-2 antibody assays—Choice of assay depends on intended use. International Journal of Infectious Diseases, 103, 381-388.
Rosón, P., Pisula, P., Báez, G., Loza, C., Taito, I., Cisneros, V., & Franco, J. V. A. (2020). Métodos diagnósticos para la infección por SARS-CoV-2. Rev. Hosp. Ital. B. Aires (2004), 117-125.
Tuaillon, E., Bollore, K., Pisoni, A., Debiesse, S., Renault, C., Marie, S., & Van de Perre, P. (2020). Detection of SARS-CoV-2 antibodies using commercial assays and seroconversion patterns in hospitalized patients. Journal of Infection, 81(2), e39-e45.
Van Elslande, J., Decru, B., Jonckheere, S., Van Wijngaerden, E., Houben, E., Vandecandelaere, P., & Vermeersch, P. (2020). Antibody response against SARS-CoV-2 spike protein and nucleoprotein evaluated by four automated immunoassays and three ELISAs. Clinical Microbiology and Infection, 26(11), 1557-e1.
Whitman, J. D., Hiatt, J., Mowery, C. T., Shy, B. R., Yu, R., Yamamoto, T. N., & Marson, A. (2020). Evaluation of SARS-CoV-2 serology assays reveals a range of test performance. Nature biotechnology, 38(10), 1174-1183.
Zakary, O., Bidah, S., & Rachik, M. (2020). The Impact of Staying Home on Controlling the Propagation of COVID -19: Control Strategy. Mexican Journal of Biomedical Engineering, 42 (1), 10-26.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2021 Lucas Antonio de Oliveira Santos; Yuri Dias Macedo Campelo; Renata Paula Lima Beltrão; Gabriela de Souza Mendonça; Viviane Alves da Silva; Vanessa Meneses de Brito Campelo
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:
1) Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
2) Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
3) Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.
